Shuttle Pharmaceuticals Holdings, Inc.
Shuttle Pharmaceuticals Holdings, Inc. financial statements
Shuttle Pharmaceuticals Holdings, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | EODHD |
| Net income | −USD 11.72M | 10-K |
| Cash and equivalents | USD 334K | 10-Q |
| Total debt | USD 232.15K | EODHD |
Shuttle Pharmaceuticals Holdings, Inc. financials on 6ix · Shuttle Pharmaceuticals Holdings, Inc. on 6ix